JUPITER, Fla., Feb. 4, 2021 /PRNewswire/ -- Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has named veteran business executive Julie Kampf as an Independent Member of its Board of Directors.
For the month of December, CEO Julie Kampf of JBK Associates International kicked off a month-long series with CBS-12 News.
PALM BEACH GARDENS, Fla.–November 2, 2020 –Steven LaKind has joined executive search firm JBK Associates International as Principal.
PALM BEACH GARDENS, Fla.–July 6, 2020 –Executive search firm JBK Associates International has hired Gregory Williamson as Principal.
